KATIE GAY: Open Payments
NPI 1295431203 · SMYRNA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 51 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $370 · 2025 $1,344
Food & beverage: $1,344
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $423 |
| GENZYME CORPORATION | 4 | $181 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $167 |
| CSL Behring | 9 | $150 |
| Novartis Pharmaceuticals Corporation | 5 | $108 |
| PFIZER INC. | 3 | $82 |
| Genentech USA, Inc. | 2 | $49 |
| Ionis Pharmaceuticals, Inc. | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Cycle Pharmaceuticals Inc | 2 | $42 |
Products named: DUPIXENT, AIRSUPRA, NEFFY, BREZTRI, FASENRA, TEZSPIRE, Xolair, Rhapsido.
Industry payments across TN — which companies pay providers there.
